WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Autoneuron
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, December 10, 2003, 23(36):11469-11478

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gervasi, N.
Right arrow Articles by Leresche, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gervasi, N.
Right arrow Articles by Leresche, N.

 Previous Article  |  Next Article 

Cellular/Molecular
Pathway-Specific Action of {gamma}-Hydroxybutyric Acid in Sensory Thalamus and Its Relevance to Absence Seizures

Nicolas Gervasi,1 * Zohreh Monnier,1 * Pierre Vincent,1 Danièle Paupardin-Tritsch,1 Stuart W. Hughes,2 Vincenzo Crunelli,2 and Nathalie Leresche1

1Neurobiologie des Processus Adaptatifs, Unité Mixte de Recherche, Centre National de la Recherche Scientifique 7102-Université Pierre et Marie Curie, F-75005 Paris, France, and 2School of Biosciences, Cardiff University, Cardiff CF10 3US, United Kingdom

The systemic injection of {gamma}-hydroxybutyric acid (GHB) elicits spike and wave discharges (SWDs), the EEG hallmark of absence seizures, and represents a well established, widely used pharmacological model of this nonconvulsive epilepsy. Despite this experimental use of GHB, as well as its therapeutic use in narcolepsy and its increasing abuse, however, the precise cellular mechanisms underlying the different pharmacological actions of this drug are still unclear.

Because sensory thalamic nuclei play a key role in the generation of SWDs and sleep rhythms, and because direct injection of GHB in the ventrobasal (VB) thalamus elicits SWDs, we investigated GHB effects on corticothalamic EPSCs and GABAergic IPSCs in VB thalamocortical (TC) neurons. GHB (250 µM-10 mM) reversibly decreased the amplitude of electrically evoked EPSCs and GABAA IPSCs via activation of GABAB receptors; however, ~60% of the IPSCs were insensitive to low (250 µM-1.0 mM) GHB concentrations. The putative GHB receptor antagonist NSC 382 applied alone had a number of unspecific effects, whereas it either had no action on, or further increased, the GHB-elicited effects on synaptic currents. Low GHB concentrations (250 µM) were also effective in increasing absence-like intrathalamic oscillations evoked by cortical afferent stimulation.

These results indicate that low concentrations of GHB, similar to the brain concentrations that evoke SWDs in vivo, differentially affect excitatory and inhibitory synaptic currents in TC neurons and promote absence-like intrathalamic oscillations. Furthermore, the present data strengthen previous suggestions on the GHB mechanism of sleep promotion and will help focus future studies on the cellular mechanisms underlying its abuse.

Key words: GABAB receptors; inhibition; excitation; sleep; intrathalamic oscillations; abuse


Received July 10, 2003; revised October 14, 2003; accepted October 28, 2003.




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
D. Ulrich, V. Besseyrias, and B. Bettler
Functional Mapping of GABAB-Receptor Subtypes in the Thalamus
J Neurophysiol, December 1, 2007; 98(6): 3791 - 3795.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. Lyon, S. M. Johnston, D. G. Watson, G. McGarvie, and E. M. Ellis
Synthesis and Catabolism of {gamma}-Hydroxybutyrate in SH-SY5Y Human Neuroblastoma Cells: ROLE OF THE ALDO-KETO REDUCTASE AKR7A2
J. Biol. Chem., September 7, 2007; 282(36): 25986 - 25992.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
O. C. Snead and K. M. Gibson
{gamma}-Hydroxybutyric Acid
N. Engl. J. Med., June 30, 2005; 352(26): 2721 - 2732.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Schweitzer, M. Roberto, S. G. Madamba, and G. R. Siggins
{gamma}-Hydroxybutyrate Increases a Potassium Current and Decreases the H-Current in Hippocampal Neurons via GABAB Receptors
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 172 - 179.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-